1. Home
  2. NERV vs EDTK Comparison

NERV vs EDTK Comparison

Compare NERV & EDTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NERV
  • EDTK
  • Stock Information
  • Founded
  • NERV 2007
  • EDTK 2013
  • Country
  • NERV United States
  • EDTK China
  • Employees
  • NERV N/A
  • EDTK N/A
  • Industry
  • NERV Biotechnology: Pharmaceutical Preparations
  • EDTK Other Consumer Services
  • Sector
  • NERV Health Care
  • EDTK Real Estate
  • Exchange
  • NERV Nasdaq
  • EDTK Nasdaq
  • Market Cap
  • NERV 14.6M
  • EDTK 16.7M
  • IPO Year
  • NERV 2014
  • EDTK 2020
  • Fundamental
  • Price
  • NERV $3.73
  • EDTK $1.08
  • Analyst Decision
  • NERV Hold
  • EDTK
  • Analyst Count
  • NERV 1
  • EDTK 0
  • Target Price
  • NERV $4.00
  • EDTK N/A
  • AVG Volume (30 Days)
  • NERV 8.7M
  • EDTK 3.3K
  • Earning Date
  • NERV 11-05-2025
  • EDTK 08-08-2025
  • Dividend Yield
  • NERV N/A
  • EDTK N/A
  • EPS Growth
  • NERV N/A
  • EDTK N/A
  • EPS
  • NERV N/A
  • EDTK N/A
  • Revenue
  • NERV N/A
  • EDTK $893,690.00
  • Revenue This Year
  • NERV N/A
  • EDTK N/A
  • Revenue Next Year
  • NERV N/A
  • EDTK N/A
  • P/E Ratio
  • NERV N/A
  • EDTK N/A
  • Revenue Growth
  • NERV N/A
  • EDTK N/A
  • 52 Week Low
  • NERV $1.15
  • EDTK $0.80
  • 52 Week High
  • NERV $12.46
  • EDTK $1.20
  • Technical
  • Relative Strength Index (RSI)
  • NERV 51.45
  • EDTK 55.90
  • Support Level
  • NERV $3.50
  • EDTK $1.05
  • Resistance Level
  • NERV $4.00
  • EDTK $1.08
  • Average True Range (ATR)
  • NERV 0.95
  • EDTK 0.03
  • MACD
  • NERV -0.13
  • EDTK 0.00
  • Stochastic Oscillator
  • NERV 11.92
  • EDTK 73.64

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

About EDTK Skillful Craftsman Education Technology Limited

Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.

Share on Social Networks: